Accessibility StatementSkip Navigation SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it will participate at the Piper Sandler 37 Annual Healthcare Conference. The conference will take place December 2-4, 2025, in New York, New York. Details are as follows: Piper Sandler 37 Annual Healthcare ConferenceDetails: Vik ...